a developer of peptide, peptide mimetic and small molecule agonist compounds
Industry Biotechnology
A.I.dvisor tells us that PTN and KRYS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTN and KRYS's prices will move in lockstep.
Ticker / NAME | Correlation To PTN | 1D Price Change % | ||
---|---|---|---|---|
PTN | 100% | -10.08% | ||
KRYS - PTN | 30% Poorly correlated | -3.71% | ||
DNLI - PTN | 25% Poorly correlated | -3.98% | ||
LGND - PTN | 25% Poorly correlated | -5.43% | ||
AUPH - PTN | 25% Poorly correlated | +0.60% | ||
ANVS - PTN | 25% Poorly correlated | -5.94% | ||
More |
Ticker / NAME | Correlation To PTN | 1D Price Change % |
---|---|---|
PTN | 100% | -10.08% |
peptide theme (2 stocks) | 32% Poorly correlated | -6.64% |
drugs theme (254 stocks) | 24% Poorly correlated | -1.67% |
small molecule theme (11 stocks) | 15% Poorly correlated | -2.90% |
biotechnology theme (238 stocks) | 7% Poorly correlated | -1.76% |